| | Business Summary | | US
Oncology,
Inc.
provides
comprehensive
services,
with
the
mission
of
expanding
access
and
quality
of
cancer
care
in
local
communities
and
advancing
the
delivery
of
care.
The
Company
develops,
constructs
and
manages
free
standing
cancer
centers
that
provide
treatment
areas
and
equipment
for
medical
oncology,
radiation
therapy
and
diagnostic
radiology;
expands
diagnostic
capabilities
of
practices
through
installation
and
management
of
Positron
Emission
Tomography
technology;
coordinates
and
manages
cancer
drug
research
trials
for
pharmaceutical
and
biotechnology
companies;
purchases
and
manages
the
inventory
for
cancer
related
drugs
for
affiliated
practices;
and
provides
management
and
capital
resources
to
affiliated
practices,
including
data
management,
accounting,
compliance
and
other
administrative
services. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | US
Oncology,
Inc.
is
a
national
physician
practice
management
company
focusing
exclusively
on
oncology.
The
Company
provides
comprehensive
management
services
to
oncology
practices
comprised
of
850
physicians
in
26
states.
For
the
six
months
ended
6/30/01,
revenues
rose
18%
to
$746.5
million.
Net
income
fell
47%
to
$20.6
million.
Results
reflect
services
expansion
and
higher
patient
volumes,
offset
by
the
absence
of
$27.6
million
in
gains
on
common
stock
investment. | | More
from
Market Guide: Significant
Developments |
| | | | FY1999 Pay | |
| R. Ross, 53
Chairman,
Pres, CEO | $866K | Lloyd Everson, M.D., 56
Vice
Chairman | 665K | Bruce Broussard
CFO | -- | Atul Dhir, M.D., 37
Pres,
Cancer Information and Research Group | -- | George Morgan
COO | -- | | Dollar
amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/u/uson.gif)